Sresta Natural Bio.
Ticker > Company >

Sresta Natural Bio. share price

Sresta Natural Bioproducts Ltd.

 1606   0   0

The company is currently not listed and is under IPO, so all the data might not be available.
*It is just an analytical rating of the company and not an investment advice.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

Ratios

Sales Growth

1 Year4.23%
3 Year3.97%
5 Year17.16%

Profit Growth

1 Year81.98%
3 Year-165.43%
5 Year-243.67%

ROE%

1 Year-1.42%
3 Year-0.42%

ROCE %

1 Year2.49%
3 Year3.29%

Debt/Equity

0.4365

Price to Cash Flow

0

Interest Cover Ratio

0

CFO/PAT (5 Yr. Avg.)

0

 Strengths

  • The company has an efficient Cash Conversion Cycle of 0 days.

 Limitations

  • The company has shown a poor profit growth of -165.425087409396% for the Past 3 years.
  • The company has shown a poor revenue growth of 3.9656340044792% for the Past 3 years.
  • Company has a poor ROE of -0.419118752756405% over the past 3 years.
  • Company has a poor ROCE of 3.28809647793534% over the past 3 years
  • Company has low Interest coverage ratio of 0.
  • The company has a low EBITDA margin of 0% over the past 5 years.

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
Net Sales 111.29 156.42 168.54 168.64 175.78
Total Expenditure 105.29 146.67 178.02 159.74 160.64
Operating Profit 6 9.75 -9.48 8.9 15.14
Other Income 2.33 3.24 1.2 1.54 2.72
Interest 1.68 3.47 4.85 5.26 4.67
Depreciation 5.86 8.62 1.38 12.89 14.73
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.78 0.89 -14.51 -7.71 -1.55
Tax 0.29 1.45 -3.65 -0.71 -0.29
Net Profit 0.49 -0.55 -10.87 -7 -1.26
Adjusted EPS (Rs.) 0.34 -0.38 -6.22 -4 -0.69

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
Equity and Liabilities
Share Capital 17.53 19.29 18.78 18.81 18.25
Total Reserves 53.8 71.96 78.39 71.45 70.81
Borrowings 3 5.54 5.02 4.9 2.34
Other N/C liabilities -1.82 -0.39 -4.01 -4.79 -4.92
Current liabilities 38.07 53.92 50.52 60.39 71.41
Total Liabilities 110.58 150.32 148.71 150.76 157.88
Assets
Net Block 8.94 17.27 17.82 17.3 16.39
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 5.49 5.49 5.49 5.2 5.2
Loans & Advances 19.43 19.4 1.02 0.92 0.91
Other N/C Assets 0 0 19.47 20.9 18.15
Current Assets 76.72 108.17 104.91 106.45 117.23
Total Assets 110.58 150.32 148.71 150.76 157.88
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2018 Mar 2019
Profit from operations -7.71 -1.55
Adjustment 4.1 7.58
Changes in Assets & Liabilities 13.6 -5.26
Tax Paid 0.71 0.14
Operating Cash Flow 10.7 0.91
Investing Cash Flow -0.88 -0.61
Financing Cash Flow -8.86 1.02
Net Cash Flow 0.96 1.32

Corporate Actions

Last Updated on:
Brief about Sresta Natural Bio.
X